ArticleFrontiers in oncology2022

Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer.

Jo-Ni Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.